AstraZeneca Plant Expansion to Double Production of Lokelma
Newly expanded manufacturing facility by AstraZeneca in Coppell, Texas will double the production of Lokelma to benefit patients from U.S. and all over world.
LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood
German pharma technology specialist. LTS Grows U.S. Footprint with the buyout of Renaissance Lakewood, the U.S. CDMO with an aim to boost its CDMO power.
Investments in the U.S. of Over $70bn Announced by Merck
Merck has announced investments in the U.S. of over $70bn in 2025 alone to mitigate supply chain risks by spreading manufacturing presence in 4 U.S. states.